Status: Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, food effect of ASC50 tablets in healthy adult participants and adult participants with mild to moderate plaque psoriasis.
Participants needed: 94
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Ascletis Pharma (China) Co., LimitedUpdated: Jun 17, 2025Locations: 1
Eligibility criteria
Male and female participants between 18 to 65 years of age inclusive, at the tim... [+2]
Female participants who are pregnant, breastfeeding or plan to be pregnant durin... [+3]